Related Experiment Video
Updated: May 20, 2026
20:24
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
Published on: January 31, 2014
Identifying combined design and analysis procedures in two-stage trials with a binary end point.
1MRC Biostatistics Unit, Cambridge, UK. jack.bowden@mrc-bsu.ac.uk
Statistics in Medicine
|July 13, 2012
Summary
Optimal two-stage trial designs balance early stopping with unbiased estimation. This research introduces methods to minimize sample size and reduce bias in clinical trial results.
Area of Science:
- Clinical Trial Design
- Biostatistics
- Pharmaceutical Research
Background:
- Two-stage trial designs offer early stopping for efficacy or futility, reducing sample size and patient exposure to ineffective treatments.
- While minimizing expected sample size is a key advantage, these designs can introduce significant bias into parameter estimates.
- Financial attractiveness and ethical benefits drive the popularity of two-stage designs in clinical research.
Purpose of the Study:
- To investigate the impact of estimation methods on two-stage trial designs.
- To identify optimal two-stage designs that balance sample size efficiency with estimator performance.
- To provide practical tools for implementing improved two-stage trial methodologies.
Main Methods:
- Review of standard and bias-adjusted maximum likelihood estimators.
- Evaluation of mean and median unbiased estimators.
- Development of optimal two-stage design and analysis procedures considering both sample size and estimator bias.
Main Results:
- Two-stage designs can lead to biased parameter estimates.
- The choice of estimation method significantly impacts the overall performance of a two-stage design.
- Optimal procedures were identified that balance sample size and estimation accuracy.
Conclusions:
- Consideration of estimator performance is crucial when selecting two-stage trial designs.
- New methodologies and software are available to implement bias-aware optimal two-stage designs.
- This approach enhances the reliability and efficiency of clinical trials.
Related Concept Videos
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:25Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
02:01Group Design
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...
02:01Factorial Design
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...